A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group

被引:3
|
作者
Crawford, E. David [1 ,15 ]
Garnick, Marc B. [2 ]
Eckel, Robert H. [3 ]
Miner, Martin M. [4 ]
Freedland, Stephen J. [5 ]
Pachynski, Russell K. [6 ]
Wassersug, Richard J. [7 ]
Rosenberg, Matthew T. [8 ]
Walker, Lauren M. [9 ]
Fairman, Ciaran [10 ]
Curley, Tracy [11 ]
Crosby, Michael [12 ]
Lin, Pao-Hwa [13 ]
Hafron, Jason M. [14 ]
机构
[1] Univ Calif San Diego, Dept Urol, La Jolla, CA USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Univ Colorado Denver, Anschutz Med Ctr, Div Endocrinol Metab & Diabet, Aurora, CO USA
[4] Brown Univ, Warren Alpert Sch Med, Providence, RI USA
[5] Cedars Sinai Med Ctr, Ctr Integrated Res Canc & Lifestyle, Los Angeles, CA USA
[6] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[7] Univ British Columbia, Vancouver, BC, Canada
[8] Midmichigan Hlth Ctr, Jackson, MI USA
[9] Univ Calgary, Dept Oncol, Dept Psychol, Calgary, AB, Canada
[10] Univ South Carolina, Dept Exercise, Columbia, SC USA
[11] Mem Sloan Kettering Canc Ctr, New York, NY USA
[12] Vet Prostate Canc Awareness Inc, San Diego, CA USA
[13] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[14] Michigan Inst Urol, West Bloomfield, MI USA
[15] Univ Calif San Diego, Dept Urol, Koman Family Outpatient Pavilion, La Jolla, CA 92037 USA
关键词
prostatic neoplasms; hormonal therapy; adverse effects; quality of life; lifestyle risk reduction; QUALITY-OF-LIFE; STYLE DIETARY PATTERN; CARDIOVASCULAR-DISEASE; RISK; MODALITIES; FRACTURE; FATIGUE; PATIENT;
D O I
10.1097/UPJ.0000000000000473
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction:To promote comprehensive care of patients throughout the androgen deprivation therapy (ADT) prescribing process, the Prostate Cancer 360 (PC360) Working Group developed monitoring and management recommendations intended to mitigate or prevent ADT-associated adverse events.Methods:The PC360 Working Group included 14 interdisciplinary experts with a dedicated clinical interest in prostate cancer and ADT management. The working group defined challenges associated with ADT adverse event management and then collaboratively developed comprehensive care recommendations intended to be practical for ADT prescribers.Results:The PC360 Working Group developed both overarching recommendations for ADT adverse event management and specific recommendations across 5 domains (cardiometabolic, bone, sexual, psychological, and lifestyle). The working group recommends an interdisciplinary, team-based approach wherein the ADT prescriber retains an oversight role for ADT management while empowering patients and their primary and specialty care providers to manage risk factors. The PC360 recommendations also emphasize the importance of proactive patient education that involves partners or other support providers. Recommended monitoring and assessment tools, risk factor management, and patient counseling points are also included for the 5 identified domains, with an emphasis on lifestyle and behavioral interventions that can improve quality of life and reduce the risk for ADT-associated complications.Conclusions:Comprehensive care of patients receiving ADT requires early and ongoing coordinated management of a variety of health domains, including cardiometabolic, bone, sexual, psychological health. Patient education and primary care provider involvement should begin prior to ADT initiation and continue throughout treatment to improve patient and partner quality of life.
引用
收藏
页码:18 / 29
页数:14
相关论文
共 50 条
  • [41] Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer
    Gild, Philipp
    Cole, Alexander P.
    Krasnova, Anna
    Dickerman, Barbra A.
    von Landenberg, Nicolas
    Sun, Maxine
    Mucci, Lorelei A.
    Lipsitz, Stuart R.
    Chun, Felix K. -H.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2018, 200 (03): : 573 - 580
  • [42] ORGASM PROFILES IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Teloken, Patrick
    Mazzola, Clarisse R.
    Mulhall, John P.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E572 - E572
  • [43] Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer
    K. Hamilton
    S. K. Chambers
    M. Legg
    J. L. Oliffe
    P. Cormie
    Supportive Care in Cancer, 2015, 23 : 133 - 142
  • [44] Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer
    Chang, David
    Joseph, David J.
    Ebert, Martin A.
    Galvao, Daniel A.
    Taaffe, Dennis R.
    Denham, James W.
    Newton, Robert U.
    Spry, Nigel A.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (02) : 223 - 228
  • [45] Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancerStatement from the DEGRO working group on prostate cancer
    Marcus Beck
    Dirk Böhmer
    Daniel M. Aebersold
    Clemens Albrecht
    Michael Flentje
    Ute Ganswindt
    Stefan Höcht
    Tobias Hölscher
    Arndt-Christian Müller
    Peter Niehoff
    Michael Pinkawa
    Felix Sedlmayer
    Daniel Zips
    Sebastian Zschaeck
    Volker Budach
    Thomas Wiegel
    Pirus Ghadjar
    Strahlentherapie und Onkologie, 2020, 196 : 109 - 116
  • [46] Taking the first steps in establishing recommendations for testosterone monitoring in men with prostate cancer on androgen-deprivation therapy
    Morales, Alvaro
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (06): : 210 - 211
  • [47] Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy
    Deka, Rishi
    Rose, Brent S.
    Bryant, Alex K.
    Sarkar, Reith R.
    Nalawade, Vinit
    McKay, Rana
    Murphy, James D.
    Simpson, Daniel R.
    CANCER, 2019, 125 (07) : 1070 - 1080
  • [48] Androgen deprivation therapy for prostate cancer: Implications for cardiometabolic clinical care
    L. Collins
    N. Mohammed
    T. Ahmad
    S. Basaria
    Journal of Endocrinological Investigation, 2012, 35 : 332 - 339
  • [49] Androgen deprivation therapy for prostate cancer: Implications for cardiometabolic clinical care
    Collins, L.
    Mohammed, N.
    Ahmad, T.
    Basaria, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (03) : 332 - 339
  • [50] Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy - Recommendations for diagnosis and therapies
    Diamond, TH
    Higano, CS
    Smith, MR
    Guise, TA
    Singer, FR
    CANCER, 2004, 100 (05) : 892 - 899